Table 2.
Active and ordinary Herpes Zoster vaccination campaign uptake among 1958 cohort.
| Cohort | 2023 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. 1 (n = 2719) | No. 2 (n = 5117) | No. 3 (n = 4520) | No. 4 (n = 2402) | Overall (n = 14.791) |
||||||||||
| Active | Ordinary | Overall Uptake * | Active | Ordinary | Overall Uptake * | Active | Ordinary | Overall Uptake * | Active | Ordinary | Overall Uptake * | |||
| 1958 | M | 121 (4.5) | 79 (2.9) | 480 (17.7) | 190 (3.7) | 182 (3.6) | 685 (13.4) | 95 (2.1) | 112 (2.5) | 459 (10.2) | 70 (2.9) | 103 (4.3) | 372 (15.5) | 1993 (13.5) |
| F | 161 (5.9) | 119 (4.4) | 229 (4.5) | 84 (1.6) | 93 (2.1) | 159 (3.5) | 80 (3.3) | 119 (5.0) | ||||||
* Cohort vaccination coverage until 3 July 2023.